Arlington Financial Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1716539 SANTA BARBARA, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$353,780

+$18,409 QoQ

Shares Held

1,393

+1.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#4,020

of 4,664 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Arlington Financial Advisors, LLC holds $15,667,328 across 4 Drug Manufacturers - General names. JNJ ranks #4 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	25,453	$9,217,040
2	GILD	Gilead Sciences, Inc.	43,432	$5,487,198
3	LLY	ELI LILLY & Co	508	$609,310
4	JNJ	Johnson & Johnson This page	1,393	$353,780

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$353,780	1,393	+1.5%	Shares	Sole	2026-07-22
2026-03-31	$335,371	1,372	-0.5%	Shares	Sole	2026-04-15
2025-12-31	$285,384	1,379	+5.7%	Shares	Sole	2026-01-12
2025-09-30	$241,973	1,305	-75.6%	Shares	Sole	2025-10-10
2025-03-31	$885,917	5,342	+365.7%	Shares	Sole	2025-04-09
2022-12-31	$202,617	1,147	-6.5%	Shares	Sole	2023-01-19
2022-09-30	$200,442	1,227	+2.6%	Shares	Sole	2022-10-19
2021-12-31	$204,599	1,196	-7.0%	Shares	Sole	2022-01-18
2021-09-30	$207,689	1,286	-68.3%	Shares	Sole	2021-11-12
2021-06-30	$668,514	4,058	+1.2%	Shares	Sole	2021-07-30
2021-03-31	$658,714	4,008	-4.2%	Shares	Sole	2021-04-23
2020-12-31	$658,320	4,183	-25.5%	Shares	Sole	2021-01-29
2020-09-30	$836,407	5,618	+32.4%	Shares	Sole	2020-11-03
2020-06-30	$596,833	4,244	-29.5%	Shares	Sole	2020-07-15
2020-03-31	$789,402	6,020	—	Shares	Sole	2020-04-09
No filing history on record for this holder in this stock.